Variant · Snv
TP53 P72R
CI-VAR-00003390Explore in graph →NP_000537.3:p.Pro72ArgNM_000546.5:c.215C>GClinVar 12351 CIViC 531 rs1042522
Curated evidence
Evidence by cancer (3 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 12840112
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Lung Carcinoma1 | ||||||||
| TP53 P72R | (prognostic) | Prognostic | B | Does Not Support Poor Outcome | 3 | accepted | EID1303Pooled data from 13 studies of patients with lung cancer found little effect of codon 72 allele on the overall survival of patients with lung cancer. Proline homozygous patients were correlated with s… (full text at CIViC) PMID 12840112 · Matakidou et al., 2003 · Open in CIViC | civic |
| Malignant Cervical Neoplasm1 | ||||||||
| TP53 P72R | (prognostic) | Prognostic | B | Does Not Support Poor Outcome | 2 | accepted | EID1304In a relatively small meta-analysis of 119 women with cervical cancer and 127 controls, associations with homozygosity for arginine, and heterozygosity at this locus were both associated with odds rat… (full text at CIViC) PMID 11535556 · | |
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 12351 | Benign | reviewed by expert panel | 3 | TP53 POLYMORPHISM; Hereditary cancer-predisposing syndrome; Li-Fraumeni syndrome 1; Li-Fraumeni syndrome; Hereditary breast ovarian cancer syndrome; Acute myeloid leukemia; Neoplasm; Cervical cancer | germline/somatic | 34 | Dec 05, 2025 | clinvar |